cDNA provides a DNA form of the original RNA sequence for the amplification stage. Because reverse transcriptase uses the RNA template before polymerase chain reaction begins, the method can retain information from RNA molecules that reflects gene expression or an RNA-based pathogen. This ordering links the initial RNA target to the later amplified product, making the conversion step essential for interpreting the assay.
Each cycle first separates the DNA strands through denaturation, then allows primers to anneal to their selected sequences, and ends with DNA extension. Repeating this sequence increases the amount of the chosen target, rather than broadly copying all nucleic acids in the sample. Primer selection therefore determines which transcript or pathogen-derived sequence the assay examines.
An RNA target requires the conversion step because the amplification stage operates on cDNA. In this sense, reverse transcriptase PCR differs from a DNA-focused PCR workflow, which would not need reverse transcriptase to create cDNA from RNA. This distinction matters when the biological question concerns gene expression or an RNA-based pathogen rather than a DNA sequence.
A basic workflow begins with an RNA template and reverse transcriptase synthesis of cDNA. The resulting cDNA then enters PCR, where denaturation, primer annealing, and DNA extension occur repeatedly. The selected target is amplified during these cycles, producing material for analysis of the RNA-derived sequence. This two-stage order keeps RNA conversion conceptually separate from amplification.
In immunology and infection studies, RT-PCR can examine cytokine transcripts and other immune-gene transcripts. Comparing these transcript signals across samples or conditions can help investigators assess host responses associated with infection. This use connects molecular RNA measurements with questions about immune activation and host-pathogen interactions, while keeping the assay focused on selected genes.
For RNA-based pathogens, RT-PCR can identify viral genomes and support infection diagnosis and disease surveillance. Repeated or comparative measurements can also monitor changes in pathogen burden or in host response transcripts. These outputs provide complementary information: one concerns detection of viral genetic material, while the other concerns transcriptional changes associated with the infection.